Application of built-in adjuvants for epitope-based vaccines
Several studies have shown that epitope vaccines exhibit substantial advantages over conventional vaccines. However, epitope vaccines are associated with limited immunity, which can be overcome by conjugating antigenic epitopes with built-in adjuvants (e.g., some carrier proteins or new biomaterials...
Main Authors: | Yao Lei, Furong Zhao, Junjun Shao, Yangfan Li, Shifang Li, Huiyun Chang, Yongguang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/6185.pdf |
Similar Items
-
Peptide Vaccine: Progress and Challenges
by: Weidang Li, et al.
Published: (2014-07-01) -
In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives
by: Yarong Zeng, et al.
Published: (2023-12-01) -
Editorial: Epitope Discovery and Synthetic Vaccine Design
by: Clarisa Beatriz Palatnik-de-Sousa, et al.
Published: (2018-04-01) -
Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021-01-01) -
An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators
by: Nidhi Chauhan, et al.
Published: (2017-05-01)